betamethasone-17,21-dipropionate and Hypercalcemia

betamethasone-17,21-dipropionate has been researched along with Hypercalcemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ikumi, K; Kubo, R; Morita, A; Muramatsu, S; Nishida, E; Sagawa, Y; Saito, C; Torii, K	1

Other Studies

1 other study(ies) available for betamethasone-17,21-dipropionate and Hypercalcemia

Article	Year
Low incidence of hypercalcemia following combined calcipotriol hydrate/betamethasone dipropionate ointment treatment in Japanese patients with severe psoriasis vulgaris. The Journal of dermatological treatment, 2018, Volume: 29, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Calcium; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Incidence; Japan; Male; Middle Aged; Ointments; Psoriasis; Severity of Illness Index; Treatment Outcome	2018

Article

Year

Low incidence of hypercalcemia following combined calcipotriol hydrate/betamethasone dipropionate ointment treatment in Japanese patients with severe psoriasis vulgaris.

The Journal of dermatological treatment, 2018, Volume: 29, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Calcium; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Incidence; Japan; Male; Middle Aged; Ointments; Psoriasis; Severity of Illness Index; Treatment Outcome

2018